CELLSOURCE CO LTDCELLSOURCE CO LTDCELLSOURCE CO LTD

CELLSOURCE CO LTD

No trades
See on Supercharts

4880 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

CellSource Co., Ltd. engages in regenerative medicine related business. Its business includes fat, blood-derived tissue and cell processing service. It also offers regenerative medicine legal support service, sale of medical device, cosmetics and facial products. It operates through the Regenerative Medicine-related and Consumer business segments. The Regenerative Medicine-related segment handles stem cell processing contract service, blood derived processing contract service and consulting service. It also sells equipment necessary for medical institutions to collect fat from patients. The Consumer segment mainly manufactures and sells cosmetics for the general consumer, such as beauty liquids, creams, facial cleansing gels, and own cosmetic brand SIGNALIFT. The company was founded on November 30, 2015 and is headquartered in Tokyo, Japan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

4880 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company